drugset / Trial / NCT03775187

Expanded Access to Burosumab

NCT03775187 ↗

Expanded access Available Kyowa Kirin, Inc.

Summary

Individual patient expanded access requests may be considered for patients who have no other treatment options

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Burosumab Monoclonal antibody — —